TERT promoter mutations in cancer development.

Area of Science:

• Genetics
• Molecular Biology
• Oncology

Background:

• Human telomerase reverse transcriptase (TERT) is crucial for maintaining genomic integrity.
• TERT expression is typically repressed in somatic cells but upregulated in cancer, contributing to cell immortality.
• The mechanisms driving TERT activation in cancer have largely remained unclear.

Purpose of the Study:

• To review the discovery of TERT promoter mutations in cancer.
• To discuss the implications of these mutations for TERT activation and cancer development.
• To explore the role of these mutations in melanoma and other cancers.

Main Methods:

• Literature review of studies on TERT promoter mutations.
• Analysis of genetic data from cancer patients.
• Examination of the functional impact of mutations on TERT expression.

Main Results:

• Germline and somatic mutations in the TERT promoter have been identified in various cancers, including melanoma.
• These mutations create novel E-twenty six/ternary complex factors (Ets/TCF) binding sites.
• The newly formed binding sites are associated with increased TERT expression.

Conclusions:

• TERT promoter mutations offer a potential explanation for tumor-specific TERT upregulation.
• These findings provide insight into the mechanisms of cancer cell immortality.
• Targeting TERT activation pathways may represent a therapeutic strategy for cancers with these mutations.